WO2002080877A3 - Utilisation de l'alverine ou l'un de ses sels - Google Patents

Utilisation de l'alverine ou l'un de ses sels Download PDF

Info

Publication number
WO2002080877A3
WO2002080877A3 PCT/FR2002/001236 FR0201236W WO02080877A3 WO 2002080877 A3 WO2002080877 A3 WO 2002080877A3 FR 0201236 W FR0201236 W FR 0201236W WO 02080877 A3 WO02080877 A3 WO 02080877A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
alverine
salts
slimming
silhouette
Prior art date
Application number
PCT/FR2002/001236
Other languages
English (en)
Other versions
WO2002080877A2 (fr
Inventor
Christel Liviero
Lionel Breton
Original Assignee
Oreal
Christel Liviero
Lionel Breton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Christel Liviero, Lionel Breton filed Critical Oreal
Publication of WO2002080877A2 publication Critical patent/WO2002080877A2/fr
Publication of WO2002080877A3 publication Critical patent/WO2002080877A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

La présente invention concerne l'utilisation dans une composition ou pour la préparation d'une composition, de l'alvérine ou de l'un de ses sels comme agoniste des récepteur β3-adrénergique. L'invention concerne en particulier l'utilisation de l'alvérine ou de l'un de ses sels dans une composition ou pour la préparation d'une composition, en tant qu'agent amincissant. Elle concerne en outre une composition cosmétique amincissante comprenant dans un milieu cosmétiquement acceptable de l'alvérine ou l'un de ses sels et un procédé de traitement cosmétique destiné à favoriser l'amincissement ou l'affinement du corps et de la silhouette ou de certaines parties du corps et de la silhouette, caractérisé par le fait que l'on applique sur la peau une telle composition.
PCT/FR2002/001236 2001-04-09 2002-04-09 Utilisation de l'alverine ou l'un de ses sels WO2002080877A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104810A FR2823114B1 (fr) 2001-04-09 2001-04-09 Utilisation de l'alverine ou de l'un de ses sels
FR01/04810 2001-04-09

Publications (2)

Publication Number Publication Date
WO2002080877A2 WO2002080877A2 (fr) 2002-10-17
WO2002080877A3 true WO2002080877A3 (fr) 2002-11-21

Family

ID=8862114

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/001236 WO2002080877A2 (fr) 2001-04-09 2002-04-09 Utilisation de l'alverine ou l'un de ses sels

Country Status (2)

Country Link
FR (1) FR2823114B1 (fr)
WO (1) WO2002080877A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10308852A1 (de) * 2003-02-27 2004-09-09 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Mittel gegen Faltenbildung der Haut
FR2936149B1 (fr) 2008-09-23 2013-01-04 Francois Fauran Utilisation de l'alverine dans le traitement des affections cutanees

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08165276A (ja) * 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd ２−アルキルアミノ−１−フェニルエタノール誘導体
FR2798590A1 (fr) * 1999-09-21 2001-03-23 Oreal Utilisation de l'alverine pour diminuer les rides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08165276A (ja) * 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd ２−アルキルアミノ−１−フェニルエタノール誘導体
FR2798590A1 (fr) * 1999-09-21 2001-03-23 Oreal Utilisation de l'alverine pour diminuer les rides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002189495, retrieved from STN Database accession no. 1996:563182 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002189496, retrieved from STN Database accession no. 1996:35922 *

Also Published As

Publication number Publication date
WO2002080877A2 (fr) 2002-10-17
FR2823114A1 (fr) 2002-10-11
FR2823114B1 (fr) 2003-05-23

Similar Documents

Publication Publication Date Title
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
HK1091151A1 (en) Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
HK1073773A1 (en) Composition, apparatus and method for skin rejuvenation
WO2001078702A3 (fr) Procedes et compositions de modulation de l'activite des recepteurs adrenergiques alpha
WO2004021968A3 (fr) Solution destinee a une application ungueale et peri-ungueale
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
WO2001085106A3 (fr) Produit cosmetique comprenant des derives de 2-furanone
WO1999004752A3 (fr) Procede pour le traitement de la pigmentation de la peau
EP1077063A3 (fr) Méthodes pour agir sur la pigmentation de la peau
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
WO2001060347A3 (fr) Methode de traitement des douleurs oculaires
HK1073264A1 (en) Cosmetic use of phytosphingosine as a slimming agent and cosmetic compositions containing phytosphingosine
EP1411882A4 (fr) Matieres premieres pour cosmetiques aux proprietes ameliorees et procedes de preparation
EP1582195A4 (fr) Agent de blanchiment, preparation de soin cutane a usage externe et produit cosmetique
WO2002080878A3 (fr) Produit bronzant et filtrant
WO2003054025A3 (fr) Polysaccharide amphotere, composition et utilisation
HUP0401773A3 (en) Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
WO2002080877A3 (fr) Utilisation de l'alverine ou l'un de ses sels
EP0967276A3 (fr) Agent antitumorale comprenant le salmosine
WO2002070638A3 (fr) Composition et procedes fondes sur une huile essentielle antimicrobienne extraite de coleus forskohlii
WO2002038110A3 (fr) Utilisation de carbohydrate pour ameliorer la fonction barriere de la peau
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
AU3290200A (en) Treatment agents for textiles, method of producing same and their use
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
WO2004050010A3 (fr) Composition, en particulier composition cosmetique, contenant au moins un parahydroxybenzoate d'alkyle et au moins un derive d'acide amine lipophile

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP